Literature DB >> 27225434

Dietary epicatechin intake and 25-y risk of cardiovascular mortality: the Zutphen Elderly Study.

James I Dower1, Johanna M Geleijnse1, Peter Ch Hollman2, Sabita S Soedamah-Muthu3, Daan Kromhout3.   

Abstract

BACKGROUND: Prospective cohort studies have shown that the consumption of cocoa and tea is associated with lower risk of cardiovascular diseases (CVDs), and cocoa and tea have been shown to improve CVD risk factors in randomized controlled trials. Cocoa and tea are major dietary sources of the flavan-3-ol epicatechin.
OBJECTIVE: We investigated the associations of dietary epicatechin intake with 25-y CVD mortality in elderly Dutch men.
DESIGN: We used data from the Zutphen Elderly Study, which was a prospective cohort study of 774 men aged 65-84 y in 1985. Epicatechin intake was estimated 4 times in 15 y with the use of the crosscheck dietary history method. Time-dependent Cox proportional hazards models were used to investigate repeated measures of epicatechin intake in relation to 25-y CVD mortality.
RESULTS: Mean intake of epicatechin was 15.2 ± 7.7 mg/d, and the major dietary sources were tea (51%), apples (28%), and cocoa (7%). During 25 y of follow-up, 329 men died from CVD, 148 died from coronary heart disease (CHD), and 72 men died from stroke. Risk of CHD mortality was 38% lower in men in the top tertile of epicatechin intake than in men in the bottom tertile of epicatechin intake (HR: 0.62; 95% CI: 0.39, 0.98). Epicatechin intake was also significantly associated with 46% lower risk of CVD mortality in men with prevalent CVD (HR: 0.54; 95% CI: 0.31, 0.96) but not in men who were free of CVD.
CONCLUSIONS: We show, for the first time to our knowledge, that epicatechin intake is inversely related to CHD mortality in elderly men and to CVD mortality in prevalent cases of CVD. More studies are needed before conclusions can be drawn.
© 2016 American Society for Nutrition.

Entities:  

Keywords:  cardiovascular disease; cocoa; epicatechin; flavan-3-ols; tea

Mesh:

Substances:

Year:  2016        PMID: 27225434     DOI: 10.3945/ajcn.115.128819

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  7 in total

1.  A pilot study on clinical pharmacokinetics and preclinical pharmacodynamics of (+)-epicatechin on cardiometabolic endpoints.

Authors:  Aldo Moreno-Ulloa; Nayelli Nájera-García; Marcela Hernández; Israel Ramírez-Sánchez; Pam R Taub; Yongxuan Su; Ernesto Beltrán-Partida; Guillermo Ceballos; Sundeep Dugar; George Schreiner; Brookie M Best; Theodore P Ciaraldi; Robert R Henry; Francisco Villarreal
Journal:  Food Funct       Date:  2018-01-24       Impact factor: 5.396

Review 2.  The Effects of Flavonoids on Cardiovascular Health: A Review of Human Intervention Trials and Implications for Cerebrovascular Function.

Authors:  Amy Rees; Georgina F Dodd; Jeremy P E Spencer
Journal:  Nutrients       Date:  2018-12-01       Impact factor: 5.717

Review 3.  Effects and Mechanisms of Tea and Its Bioactive Compounds for the Prevention and Treatment of Cardiovascular Diseases: An Updated Review.

Authors:  Shi-Yu Cao; Cai-Ning Zhao; Ren-You Gan; Xiao-Yu Xu; Xin-Lin Wei; Harold Corke; Atanas G Atanasov; Hua-Bin Li
Journal:  Antioxidants (Basel)       Date:  2019-06-06

4.  (-)-Epicatechin Ameliorates Monosodium Urate-Induced Acute Gouty Arthritis Through Inhibiting NLRP3 Inflammasome and the NF-κB Signaling Pathway.

Authors:  Chenxi Wu; Fenfen Li; Xiaoxi Zhang; Wenjing Xu; Yan Wang; Yanjing Yao; Ziwei Han; Daozong Xia
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

5.  Metabolic and Cardiovascular Benefits of Apple and Apple-Derived Products: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Sun Jo Kim; Nguyen Hoang Anh; Cheol Woon Jung; Nguyen Phuoc Long; Seongoh Park; Young Hyun Cho; Young Cheol Yoon; Eun Goo Lee; Mina Kim; Eui Young Son; Tae Ha Kim; Yingqian Deng; Johan Lim; Sung Won Kwon
Journal:  Front Nutr       Date:  2022-04-05

6.  Dietary intakes of flavan-3-ols and cardiometabolic health: systematic review and meta-analysis of randomized trials and prospective cohort studies.

Authors:  Gowri Raman; Esther E Avendano; Siyu Chen; Jiaqi Wang; Julia Matson; Bridget Gayer; Janet A Novotny; Aedín Cassidy
Journal:  Am J Clin Nutr       Date:  2019-11-01       Impact factor: 7.045

Review 7.  Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials.

Authors:  Binh Yen Nguyen; Andrea Ruiz-Velasco; Thuy Bui; Lucy Collins; Xin Wang; Wei Liu
Journal:  Br J Pharmacol       Date:  2018-08-02       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.